4.2 Host and Environmental Risk Factors for Infection

Host and Environmental Risk Factors for Infection

Susceptibility to infectious diseases reflects the dynamic interplay between pathogen virulence, inoculum size, and host immune competence. When natural epithelial barriers are breached or immune surveillance mechanisms are blunted by chronic disease, the minimal infective dose drops precipitously. Infectious diseases specialists must identify patient-specific anatomic, metabolic, and environmental vulnerabilities to design targeted diagnostic investigations, direct appropriate source control, and select effective empiric antimicrobial therapy.

---

Anatomical and Barrier Disruption: Foreign Bodies and Invasive Devices

The Foreign Body Effect and Biofilm Pathophysiology

The presence of an artificial foreign body (prosthetic joint, mechanical valve, vascular graft, central line) reduces the minimal inoculum of Staphylococcus aureus required to establish infection by more than 10,000-fold (from 10^6 CFU to <100 CFU). Foreign biomaterials are rapidly coated with host extracellular matrix proteins (fibronectin, fibrinogen, vitronectin, collagen), providing docking ligands for bacterial surface adhesins (MSCRAMMs—microbial surface components recognizing adhesive matrix molecules).

Phase 1: Reversible Adhesion   Phase 2: Irreversible Binding  Phase 3: Maturation & EPS Matrix   Phase 4: Dispersal
       Bacteria                       MSCRAMMs bind host             Biofilm Matrix (PIA/eDNA)         Bacteremic Shower
          ▼                                 ligands                  Metabolically Dormant Persisters     Metastatic Foci
   ○   ○   ○   ○                      ●───●───●───●                  ████████████████████████            ○       ○
─────────────────────              ─────────────────────             ─────────────────────────        ───────   ───────
  Prosthetic Surface                 Prosthetic Surface                  Prosthetic Surface             Prosthetic Surface

Biofilm formation proceeds through four discrete stages:

1. Reversible Attachment: Planktonic bacteria contact the protein-conditioned biomaterial via electrostatic and hydrophobic interactions.
2. Irreversible Binding: Bacterial adhesins lock onto host proteins; in staphylococci, the icaADBC operon is transcribed, synthesizing polysaccharide intercellular adhesin (PIA), a linear beta-1,6-linked glucosaminoglycan that glues cells together.
3. Maturation and Matrix Secretion: Microcolonies encase themselves in an extracellular polymeric substance (EPS) matrix composed of exopolysaccharides, extracellular DNA (eDNA), and amyloid fibers. Fluid channels circulate nutrients, and metabolic gradients establish an anaerobic, acidic core.
4. Phenotypic Tolerance and Persister Cells: Deep within the biofilm, bacteria downregulate metabolic activity, entering a non-dividing, stationary-phase "persister" state. Because cell-wall active agents (beta-lactams, vancomycin) require active cell division and peptidoglycan cross-linking to exert bactericidal activity, persisters exhibit profound phenotypic tolerance (MICs can increase 100- to 1,000-fold despite genetic susceptibility).
5. Detachment and Dispersal: Enzymatic cleavage of the matrix releases planktonic bacteria, producing recurrent bacteremia, systemic sepsis, and metastatic seeding.

Clinical Syndromes of Foreign Body Infections

Invasive Vascular Lines and Catheter-Associated Infections

                Extraluminal Route                                Intraluminal Route
      (Dominant in short-term lines <14 days)           (Dominant in long-term lines >14 days)
                 Skin Flora                                         Hub Contamination
         (S. aureus, S. epidermidis)                            (Contaminated hands/infusates)
                     │                                                        │
                     ▼                                                        ▼
         Migrates down insertion tract                         Travels inside lumen to tip
                     │                                                        │
                     └───────────────────────┬────────────────────────────────┘
                                             ▼
                              Fibrin Sheath & Biofilm at Tip
                                             │
                                             ▼
                              CLABSI & Metastatic Seeding

• CLABSI Pathogenesis: In short-term central venous catheters (CVCs; <14 days), extraluminal migration of skin microorganisms along the external catheter tract is the dominant route. In long-term catheters (>14 days, e.g., Hickman, Port-a-Cath, PICC), intraluminal contamination via hub manipulation dominates. Risk by site: Femoral (highest bacterial burden, avoid in adults) > Internal Jugular > Subclavian (lowest infection rate).
• Mandatory Catheter Removal Criteria: Immediate line removal is required for:
  1. Staphylococcus aureus or Candida species bacteremia/fungemia.
  2. Pseudomonas aeruginosa, multidrug-resistant Gram-negative rods, or Acinetobacter.
  3. Catheter-site tunnel infection or port-pocket abscess.
  4. Septic thrombophlebitis, endocarditis, or metastatic seeding.
  5. Persistent bacteremia >72 hours despite appropriate targeted antimicrobial therapy.
• Catheter Salvage Criteria: Reserved strictly for uncomplicated bacteremia involving coagulase-negative staphylococci or enterococci in patients with limited venous access, utilizing systemic antimicrobials combined with antibiotic lock therapy (e.g., vancomycin or ethanol locks dwell for 12–24 hours).

Other Device-Related Infections

• Endotracheal Tubes and VAP: The tube disrupts cough and mucociliary clearance, while pooled secretions above the cuff leak into the bronchial tree via microaspiration. Biofilms coat the tube lumen. VAP Prevention Bundles: Elevating head of bed 30°–45°, subglottic secretion drainage, daily sedation interruptions with spontaneous breathing trials, and avoidance of unnecessary acid suppression.
• Indwelling Urinary Catheters and CAUTI: Extraluminal ascent via periurethral mucous films occurs during catheter insertion; intraluminal retrograde ascent follows drainage bag contamination. Asymptomatic Bacteriuria (ASB) must never be treated with antimicrobials in catheterized patients (exceptions: pregnancy, planned urological procedures with mucosal trauma); treatment does not prevent CAUTI and drives antimicrobial resistance.
• Extensive Thermal Burns: Loss of the stratum corneum barrier and microvascular thrombosis create avascular, protein-rich eschar, a potent culture medium. Neutrophil chemotaxis and oxidative killing are severely impaired, leading to invasive burn sepsis caused by Pseudomonas aeruginosa (ecthyma gangrenosum-like lesions), S. aureus, and opportunistic molds (Aspergillus, Mucorales).

---

Chronic Underlying Comorbidities and Immune Dysfunction

Diabetes Mellitus and Metabolic Perturbations

Hyperglycemia drives systemic immune blunting through multiple biochemical cascades:

• Neutrophil Dysfunction: Non-enzymatic glycation of immunoglobulins and cell-surface receptors impairs neutrophil rolling, chemotaxis, adherence, and phagocytosis. Blunted intracellular generation of reactive oxygen species (superoxide anion, hydrogen peroxide) diminishes bactericidal and fungicidal oxidative burst.
• Micro- and Macrovascular Disease: Diabetic endarteritis induces local tissue ischemia, hypoxia, and impaired delivery of circulating humoral defense factors and systemically administered antimicrobials.
• Specific Infectious Syndromes:
  • Diabetic Foot Infections (DFI): Peripheral neuropathy and microvascular disease produce malperforans ulcers. Moderate-to-severe infections are characteristically polymicrobial, involving aerobic Gram-positive cocci (S. aureus, Group B streptococci), Enterobacterales (E. coli, Proteus), and obligate anaerobes (Bacteroides fragilis, Peptostreptococcus).
  • Malignant (Necrotizing) External Otitis: Invasive Pseudomonas aeruginosa infection of the external auditory canal that spreads to the temporal bone and skull base, causing cranial nerve palsies (CN VII, IX, X, XI).
  • Emphysematous Pyelonephritis / Cholecystitis: Gas-forming infections (primarily E. coli and K. pneumoniae) fueled by high tissue glucose concentrations enabling anaerobic mixed-acid fermentation.

                         Diabetic Ketoacidosis (DKA)
                                     │
                                     ▼
               Systemic Acidosis (pH < 7.35) & Hyperglycemia
                                     │
                                     ▼
              Dissociation of Iron from Host Serum Transferrin
                                     │
                                     ▼
                 Abundant Free Serum Iron Availability
                                     │
                                     ▼
    Binding to Fungal Spore CotH3 Receptors & Gtr1 Iron Permeases
                                     │
                                     ▼
           Rapid Hyphal Germination of Rhizopus / Mucorales
                                     │
                                     ▼
     Angioinvasion ──► Thrombosis ──► Black Necrotic Facial Eschar

Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)

• Uremic Immunosuppression: Uremic toxins inhibit monocyte antigen presentation, suppress T-cell blastogenesis, downregulate co-stimulatory molecules (CD80/CD86), and impair neutrophil intracellular killing.
• Vascular Access Bacteremia: Arteriovenous fistulas (AVF) carry the lowest risk of infection; arteriovenous grafts (AVG) carry intermediate risk; tunneled cuffed central catheters (TCC) carry a 10-fold higher bacteremia rate. Staphylococcus aureus (MSSA and MRSA) accounts for >50% of vascular access bacteremias and carries an exceptionally high risk of metastatic complications: infective endocarditis (up to 20%), septic arthritis, and vertebral osteomyelitis/epidural abscess.
• Peritoneal Dialysis (PD) Peritonitis: Defined by cloudy dialysate effluent, abdominal pain, and an effluent cell count >100 WBC/µL (with >50% polymorphonuclear leukocytes). Gram-positive skin flora (S. epidermidis, S. aureus) predominate, followed by enteric Gram-negatives. Intraperitoneal (IP) administration of cefazolin or vancomycin plus an aminoglycoside or cefepime is the preferred route of treatment.

Cirrhosis and Advanced Liver Failure

• Pathophysiology: Advanced cirrhosis causes loss of hepatic reticuloendothelial function (macrophages/Kupffer cells fail to clear bacteria from portal blood), portosystemic shunting (allowing portal bacteremia to bypass the liver), hypocomplementemia (defective C3/C4 hepatic synthesis), and portal hypertensive enteropathy (increased intestinal permeability and bacterial translocation).
• Spontaneous Bacterial Peritonitis (SBP): Monomicrobial infection of ascitic fluid occurring in the absence of a surgically treatable intra-abdominal source. Ascitic fluid analysis reveals an absolute neutrophil count (ANC) ≥ 250 cells/mm3 (0.25 x 10^9/L). Causative agents are enteric Gram-negative bacilli (E. coli, K. pneumoniae) or Streptococcus pneumoniae.
  • Therapy: Third-generation cephalosporin (IV ceftriaxone 2 g daily or cefotaxime 2 g q8h) plus intravenous albumin (1.5 g/kg within 6 hours, followed by 1.0 g/kg on day 3) to prevent circulatory dysfunction, hepatorenal syndrome, and death.
  • Secondary Prophylaxis: Indefinite daily oral prophylaxis with ciprofloxacin (500 mg daily) or trimethoprim-sulfamethoxazole (one DS tablet daily).
• Pathogen Vulnerabilities: Extreme susceptibility to encapsulated organisms (S. pneumoniae bacteremia) and fulminant foodborne/marine pathogens (Vibrio vulnificus), where transferrin saturation from hepatic iron overload allows explosive bacterial replication and septic shock.

Anatomical and Functional Asplenia

• Immunological Deficit: The spleen filters poorly opsonized particles from the circulation via splenic cords and red pulp macrophages. Furthermore, marginal zone B cells generate natural IgM antibodies that initiate the classical complement cascade against polysaccharide capsules, while the spleen produces critical opsonins (properdin and tuftsin). Conditions conferring functional hyposplenism include sickle cell anemia (repeated splenic auto-infarctions leading to functional asplenia by age 5), celiac disease, and severe graft-versus-host disease.

Loss of Spleen (Surgical Splenectomy or Sickle Cell Auto-Infarction)
                               │
       ┌───────────────────────┴───────────────────────┐
       ▼                                               ▼
Loss of Red Pulp Macrophages           Loss of Marginal Zone IgM Memory B Cells
(Defective filtration of poorly        (Inability to generate opsonizing antibodies
 opsonized bacteria)                    against polysaccharide capsules)
       │                                               │
       └───────────────────────┬───────────────────────┘
                               ▼
          Overwhelming Post-Splenectomy Infection (OPSI)
   Hyperacute septic shock, purpura fulminans, bilateral adrenal
      hemorrhage (Waterhouse-Friderichsen syndrome), >50% mortality
                               │
       ┌───────────────────────┼───────────────────────┐
       ▼                       ▼                       ▼
Streptococcus pneumoniae   Neisseria meningitidis   Haemophilus influenzae type b
   (>50-70% of OPSI)           (Rapid purpura)           (Pediatric risk)

• Overwhelming Post-Splenectomy Infection (OPSI): A hyperacute, catastrophic septicemia characterized by initial mild flu-like symptoms that rapidly progress within hours to fulminant septic shock, disseminated intravascular coagulation (DIC), purpura fulminans, bilateral adrenal hemorrhage (Waterhouse-Friderichsen syndrome), and mortality >50%.
• Pathogen Spectrum:
  • Encapsulated Bacteria: Streptococcus pneumoniae (accounts for >50–70% of OPSI), Neisseria meningitidis, and Haemophilus influenzae type b.
  • Zoonotic and Parasitic Threats:
    • Capnocytophaga canimorsus: Fastidious, filamentous Gram-negative rod found in normal canine and feline oral flora. Animal bites or scratches in an asplenic patient provoke fulminant sepsis, symmetrical peripheral gangrene, and purpura fulminans.
    • Babesia microti: Intraerythrocytic tick-borne protozoan (Ixodes scapularis). Because the spleen normally culls parasitized erythrocytes, asplenic patients experience uncontrolled parasitemia (>10–50% parasitemia), severe Coombs-negative hemolytic anemia, hemoglobinuria, renal failure, and death.
    • Bordetella holmesii: Can trigger invasive bacteremia mimicking pneumococcal sepsis.
• Vaccine and Prophylaxis Mandates: Asplenic patients require conjugate pneumococcal vaccination (PCV20 alone or PCV15 followed by PPSV23 ≥ 8 weeks later), meningococcal conjugates (MenACWY plus MenB), and H. influenzae type b (Hib). Patients must carry emergency standby oral antibiotics (amoxicillin-clavulanate or levofloxacin) to initiate immediately upon developing fever.

---

Environmental, Occupational, and Healthcare Exposures

Healthcare-Associated Exposures

Prior antimicrobial exposure (especially third-generation cephalosporins, fluoroquinolones, and carbapenems) destroys protective anaerobic intestinal microflora, eradicating colonization resistance. Specific exposures carry defined microbiological risks:

• Recent Hospitalization (≤ 90 days) or LTCF Residence: Colonization with methicillin-resistant S. aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, and Clostridioides difficile.
• Outpatient Hemodialysis: Clonal transmission of MRSA, multi-drug resistant Gram-negative bacilli, and bloodborne viral pathogens.

Animal, Zoonotic, and Environmental Exposure Matrix